Morgan Stanley’s Acceleron Pharma Inc. XLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-134,674
Closed -$23.2M 8392
2021
Q3
$23.2M Buy
134,674
+49,484
+58% +$8.52M ﹤0.01% 1938
2021
Q2
$10.7M Buy
85,190
+60,797
+249% +$7.63M ﹤0.01% 2898
2021
Q1
$3.31M Buy
24,393
+296
+1% +$40.1K ﹤0.01% 3835
2020
Q4
$3.08M Buy
24,097
+5,492
+30% +$703K ﹤0.01% 3780
2020
Q3
$2.09M Sell
18,605
-4,681
-20% -$527K ﹤0.01% 3619
2020
Q2
$2.22M Sell
23,286
-3,839
-14% -$366K ﹤0.01% 3504
2020
Q1
$2.44M Sell
27,125
-54,346
-67% -$4.88M ﹤0.01% 3185
2019
Q4
$4.32M Buy
81,471
+42,349
+108% +$2.25M ﹤0.01% 3351
2019
Q3
$1.55M Buy
39,122
+17,438
+80% +$689K ﹤0.01% 4012
2019
Q2
$890K Sell
21,684
-9,768
-31% -$401K ﹤0.01% 4281
2019
Q1
$1.47M Sell
31,452
-49,569
-61% -$2.31M ﹤0.01% 3842
2018
Q4
$3.53M Sell
81,021
-32,381
-29% -$1.41M ﹤0.01% 3279
2018
Q3
$6.49M Sell
113,402
-169,208
-60% -$9.69M ﹤0.01% 2903
2018
Q2
$13.7M Buy
282,610
+160,386
+131% +$7.78M ﹤0.01% 2028
2018
Q1
$4.78M Buy
122,224
+15,454
+14% +$604K ﹤0.01% 3070
2017
Q4
$4.53M Buy
106,770
+28,594
+37% +$1.21M ﹤0.01% 3215
2017
Q3
$2.92M Buy
78,176
+12,649
+19% +$472K ﹤0.01% 3514
2017
Q2
$1.99M Sell
65,527
-2,135
-3% -$64.9K ﹤0.01% 3798
2017
Q1
$1.79M Sell
67,662
-77,491
-53% -$2.05M ﹤0.01% 3904
2016
Q4
$3.7M Sell
145,153
-666,596
-82% -$17M ﹤0.01% 3311
2016
Q3
$29.4M Buy
811,749
+762,262
+1,540% +$27.6M 0.01% 1176
2016
Q2
$1.68M Sell
49,487
-36,620
-43% -$1.24M ﹤0.01% 3564
2016
Q1
$2.27M Buy
86,107
+72,915
+553% +$1.92M ﹤0.01% 3244
2015
Q4
$644K Sell
13,192
-2,845
-18% -$139K ﹤0.01% 4353
2015
Q3
$399K Sell
16,037
-3,583
-18% -$89.1K ﹤0.01% 4739
2015
Q2
$621K Sell
19,620
-417
-2% -$13.2K ﹤0.01% 4552
2015
Q1
$763K Sell
20,037
-988
-5% -$37.6K ﹤0.01% 4334
2014
Q4
$819K Sell
21,025
-120
-0.6% -$4.67K ﹤0.01% 4311
2014
Q3
$640K Sell
21,145
-1,678
-7% -$50.8K ﹤0.01% 4396
2014
Q2
$775K Sell
22,823
-162
-0.7% -$5.5K ﹤0.01% 4257
2014
Q1
$793K Sell
22,985
-16,651
-42% -$574K ﹤0.01% 4192
2013
Q4
$1.57M Buy
+39,636
New +$1.57M ﹤0.01% 3564